Healthcare & Life Sciences
Hepacure Pharma
About
Develops novel peptide therapies targeting non-alcoholic fatty liver disease (NAFLD) to reduce fat accumulation in the liver.
Explore Hepacure Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.